PinG Study

Pubertal induction with Gonadotropin Treatment in Males with Hypogonadotropic Hypogonadism 
This study aims to identify the best treatments for induction of puberty in boys and young men with delayed, absent or stalled puberty due to hypogonadotropic hypogonadism (a lack of reproductive hormones, the chemical messages that control puberty). 

We are comparing different combinations of medicines called gonadotropins (reproductive hormones that control puberty) to see what works best to help boys and young men to go through puberty and be able to make sperm (to be fertile and parent a child later in life). 

The study is organised by staff at QMUL and Barts Health NHS Trust, with Dr Sasha Howard as the Chief Investigator, with Principal Investigators at each of the study sites across England and Scotland. The study is funded by the National Institute for Health and Care Research (NIHR).